190 related articles for article (PubMed ID: 37855057)
1. Differential transcriptional control of hematopoiesis in congenital and cyclic neutropenia patients harboring
Zeidler A; Borbaran-Bravo N; Dannenmann B; Ritter M; Nasri M; Klimiankou M; Kandabarau S; Zahabi A; König J; Zeidler C; Skokowa J; Welte K
Haematologica; 2024 May; 109(5):1393-1402. PubMed ID: 37855057
[TBL] [Abstract][Full Text] [Related]
2. CRISPR-Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia.
Nasri M; Ritter MU; Mir P; Dannenmann B; Kaufmann MM; Arreba-Tutusaus P; Xu Y; Borbaran-Bravo N; Klimiankou M; Lengerke C; Zeidler C; Cathomen T; Welte K; Skokowa J
Mol Ther; 2024 Jun; 32(6):1628-1642. PubMed ID: 38556793
[TBL] [Abstract][Full Text] [Related]
3. Congenital neutropenia: From lab bench to clinic bedside and back.
Dobrewa W; Bielska M; Bąbol-Pokora K; Janczar S; Młynarski W
Mutat Res Rev Mutat Res; 2024; 793():108476. PubMed ID: 37989463
[TBL] [Abstract][Full Text] [Related]
4. ELANE mutant-specific activation of different UPR pathways in congenital neutropenia.
Nustede R; Klimiankou M; Klimenkova O; Kuznetsova I; Zeidler C; Welte K; Skokowa J
Br J Haematol; 2016 Jan; 172(2):219-27. PubMed ID: 26567890
[TBL] [Abstract][Full Text] [Related]
5. The spectrum of ELANE mutations and their implications in severe congenital and cyclic neutropenia.
Germeshausen M; Deerberg S; Peter Y; Reimer C; Kratz CP; Ballmaier M
Hum Mutat; 2013 Jun; 34(6):905-14. PubMed ID: 23463630
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of SCN and CyN induced by ELANE mutations: a systematic review.
Xiao Y; Wang N; Jin X; Liu A; Zhang Z
Front Immunol; 2024; 15():1349919. PubMed ID: 38840904
[TBL] [Abstract][Full Text] [Related]
7. New insights into the pathomechanism of cyclic neutropenia.
Mir P; Klimiankou M; Findik B; Hähnel K; Mellor-Heineke S; Zeidler C; Skokowa J; Welte K
Ann N Y Acad Sci; 2020 Apr; 1466(1):83-92. PubMed ID: 32083314
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the defective granulopoiesis in childhood cyclic neutropenia and in severe congenital neutropenia.
Sera Y; Kawaguchi H; Nakamura K; Sato T; Habara M; Okada S; Ishikawa N; Kojima S; Katoh O; Kobayashi M
Haematologica; 2005 Aug; 90(8):1032-41. PubMed ID: 16079102
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of ELANE-mutant severe neutropenia revealed by induced pluripotent stem cells.
Nayak RC; Trump LR; Aronow BJ; Myers K; Mehta P; Kalfa T; Wellendorf AM; Valencia CA; Paddison PJ; Horwitz MS; Grimes HL; Lutzko C; Cancelas JA
J Clin Invest; 2015 Aug; 125(8):3103-16. PubMed ID: 26193632
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9-mediated
Nasri M; Ritter M; Mir P; Dannenmann B; Aghaallaei N; Amend D; Makaryan V; Xu Y; Fletcher B; Bernhard R; Steiert I; Hahnel K; Berger J; Koch I; Sailer B; Hipp K; Zeidler C; Klimiankou M; Bajoghli B; Dale DC; Welte K; Skokowa J
Haematologica; 2020 Mar; 105(3):598-609. PubMed ID: 31248972
[TBL] [Abstract][Full Text] [Related]
11. Activation of the unfolded protein response is associated with impaired granulopoiesis in transgenic mice expressing mutant Elane.
Nanua S; Murakami M; Xia J; Grenda DS; Woloszynek J; Strand M; Link DC
Blood; 2011 Mar; 117(13):3539-47. PubMed ID: 21285438
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of Neutropenia-Associated Neutrophil Elastase Mutations in a Murine Differentiation Model In Vitro and In Vivo.
Wiesmeier M; Gautam S; Kirschnek S; Häcker G
PLoS One; 2016; 11(12):e0168055. PubMed ID: 27942017
[TBL] [Abstract][Full Text] [Related]
13. Mutant elastase in pathogenesis of cyclic and severe congenital neutropenia.
Aprikyan AA; Liles WC; Boxer LA; Dale DC
J Pediatr Hematol Oncol; 2002 Dec; 24(9):784-6. PubMed ID: 12468929
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Gene Editing versus a Neutrophil Elastase Inhibitor as Potential Therapies for
Makaryan V; Kelley M; Fletcher B; Archibald I; Poulsen T; Dale D
J Cell Immunol; 2022; 4(1):19-28. PubMed ID: 36052149
[TBL] [Abstract][Full Text] [Related]
15. Elastase inhibitors as potential therapies for
Makaryan V; Kelley ML; Fletcher B; Bolyard AA; Aprikyan AA; Dale DC
J Leukoc Biol; 2017 Oct; 102(4):1143-1151. PubMed ID: 28754797
[TBL] [Abstract][Full Text] [Related]
16. A Truncated Granulocyte Colony-stimulating Factor Receptor (G-CSFR) Inhibits Apoptosis Induced by Neutrophil Elastase G185R Mutant: IMPLICATION FOR UNDERSTANDING CSF3R GENE MUTATIONS IN SEVERE CONGENITAL NEUTROPENIA.
Qiu Y; Zhang Y; Hu N; Dong F
J Biol Chem; 2017 Feb; 292(8):3496-3505. PubMed ID: 28073911
[TBL] [Abstract][Full Text] [Related]
17. Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis.
Grenda DS; Murakami M; Ghatak J; Xia J; Boxer LA; Dale D; Dinauer MC; Link DC
Blood; 2007 Dec; 110(13):4179-87. PubMed ID: 17761833
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil elastase is severely down-regulated in severe congenital neutropenia independent of ELA2 or HAX1 mutations but dependent on LEF-1.
Skokowa J; Fobiwe JP; Dan L; Thakur BK; Welte K
Blood; 2009 Oct; 114(14):3044-51. PubMed ID: 19620402
[TBL] [Abstract][Full Text] [Related]
19. Neutropenia-associated ELANE mutations disrupting translation initiation produce novel neutrophil elastase isoforms.
Tidwell T; Wechsler J; Nayak RC; Trump L; Salipante SJ; Cheng JC; Donadieu J; Glaubach T; Corey SJ; Grimes HL; Lutzko C; Cancelas JA; Horwitz MS
Blood; 2014 Jan; 123(4):562-9. PubMed ID: 24184683
[TBL] [Abstract][Full Text] [Related]
20. Impact of different genetic mutations on granulocyte development and G-CSF responsiveness in congenital neutropenia.
Meng X; Zhang H; Dong L; Min Q; Yu M; Li Y; Liu L; Wang W; Ying W; Sun J; Wang JY; Hou J; Wang X
Blood Adv; 2024 Apr; 8(7):1667-1682. PubMed ID: 38286463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
